These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Rivaroxaban in patients with mechanical heart valves: A pilot study. Roost E; Weber A; Alberio L; Englberger L; Reineke D; Keller D; Nagler M; Carrel T Thromb Res; 2020 Feb; 186():1-6. PubMed ID: 31837559 [TBL] [Abstract][Full Text] [Related]
26. Usefulness and Safety of Rivaroxaban in Patients Following Isolated Mitral Valve Replacement With a Mechanical Prosthesis. Durães AR; Bitar YSL; Lima MLG; Santos CC; Schonhofen IS; Filho JAL; Roever L Am J Cardiol; 2018 Sep; 122(6):1047-1050. PubMed ID: 30098707 [TBL] [Abstract][Full Text] [Related]
27. Reduced Leaflet Motion after Transcatheter Aortic-Valve Replacement. De Backer O; Dangas GD; Jilaihawi H; Leipsic JA; Terkelsen CJ; Makkar R; Kini AS; Veien KT; Abdel-Wahab M; Kim WK; Balan P; Van Mieghem N; Mathiassen ON; Jeger RV; Arnold M; Mehran R; Guimarães AHC; Nørgaard BL; Kofoed KF; Blanke P; Windecker S; Søndergaard L; N Engl J Med; 2020 Jan; 382(2):130-139. PubMed ID: 31733182 [TBL] [Abstract][Full Text] [Related]
28. Results of rotational thromboelastometry, coagulation activation markers and thrombin generation assays in orthopedic patients during thromboprophylaxis with rivaroxaban and enoxaparin: a prospective cohort study. Oswald E; Velik-Salchner C; Innerhofer P; Tauber H; Auckenthaler T; Ulmer H; Streif W Blood Coagul Fibrinolysis; 2015 Mar; 26(2):136-44. PubMed ID: 25396759 [TBL] [Abstract][Full Text] [Related]
29. Successful use of fondaparinux for bridging early after aortic and mitral mechanical heart valve replacement. Perissinotti AJ; Dotson B; Baciewicz FA; Tennenberg SD Ann Pharmacother; 2012 Mar; 46(3):e9. PubMed ID: 22353236 [TBL] [Abstract][Full Text] [Related]
30. Periprocedural bridging therapy with low-molecular-weight heparin in chronically anticoagulated patients with prosthetic mechanical heart valves: experience in 116 patients from the prospective BRAVE registry. Hammerstingl C; Tripp C; Schmidt H; von der Recke G; Omran H J Heart Valve Dis; 2007 May; 16(3):285-92. PubMed ID: 17578050 [TBL] [Abstract][Full Text] [Related]
31. A practical approach for bridging anticoagulation after mechanical heart valve replacement. Steger V; Bail DH; Graf D; Walker T; Rittig K; Ziemer G J Heart Valve Dis; 2008 May; 17(3):335-42. PubMed ID: 18592932 [TBL] [Abstract][Full Text] [Related]
32. [Comparison of the safety of rivaroxaban versus dabigatran therapy in patients with persistent atrial fibrillation]. Gorzelak-Pabiś P; Duraj I; Szlagowska L; Ciastkowska A; Broncel M Pol Merkur Lekarski; 2014 Nov; 37(221):261-4. PubMed ID: 25546985 [TBL] [Abstract][Full Text] [Related]
33. Arterial antithrombotic activity of rivaroxaban, an orally active factor Xa inhibitor, in a rat electrolytic carotid artery injury model of thrombosis. Parry TJ; Huang Z; Chen C; Connelly MA; Perzborn E; Andrade-Gordon P; Damiano BP Blood Coagul Fibrinolysis; 2011 Dec; 22(8):720-6. PubMed ID: 21986468 [TBL] [Abstract][Full Text] [Related]
34. Dose-escalation study of rivaroxaban (BAY 59-7939)--an oral, direct Factor Xa inhibitor--for the prevention of venous thromboembolism in patients undergoing total hip replacement. Eriksson BI; Borris LC; Dahl OE; Haas S; Huisman MV; Kakkar AK; Misselwitz F; Muehlhofer E; Kälebo P Thromb Res; 2007; 120(5):685-93. PubMed ID: 17292948 [TBL] [Abstract][Full Text] [Related]
35. Rivaroxaban: a review of its use for the prophylaxis of venous thromboembolism after total hip or knee replacement surgery. Duggan ST Am J Cardiovasc Drugs; 2012 Feb; 12(1):57-72. PubMed ID: 22272729 [TBL] [Abstract][Full Text] [Related]
36. Cost-effectiveness of rivaroxaban after total hip or total knee arthroplasty. Kwong LM Am J Manag Care; 2011 Feb; 17(1 Suppl):S22-6. PubMed ID: 21517652 [TBL] [Abstract][Full Text] [Related]
37. Investigation of the effects of Enoxaparin, Fondaparinux, and Rivaroxaban used in thromboembolism prophylaxis on fracture healing in rats. Demirtas A; Azboy I; Bulut M; Ucar BY; Alabalik U; Necmioglu NS Eur Rev Med Pharmacol Sci; 2013 Jul; 17(14):1850-6. PubMed ID: 23877846 [TBL] [Abstract][Full Text] [Related]
38. [Rivaroxaban (Xarelto): efficacy and safety]. Rosencher N; Arnaout L; Chabbouh T; Bellamy L Ann Fr Anesth Reanim; 2008 Dec; 27 Suppl 3():S22-7. PubMed ID: 19185784 [TBL] [Abstract][Full Text] [Related]
39. Twenty years' single-center experience with mechanical heart valves: a critical review of anticoagulation policy. Van Nooten GJ; Caes F; François K; Van Bellleghem Y; Bové T; Vandenplas G; Taeymans Y J Heart Valve Dis; 2012 Jan; 21(1):88-98. PubMed ID: 22474748 [TBL] [Abstract][Full Text] [Related]